Paper Details

  1. Home
  2. Paper Details

Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial.

Author: CasigliaE, CiceroA F, GussoniG, LentiS, MazzaA, RamazzinaE, SchiavonL

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study investigated the efficacy of nutraceuticals containing folate, vitamin B6, B12, B2, zinc, and betaine in lowering homocysteine (HCys) levels compared to conventional vitamin supplementation in hypertensive subjects with hyper-homocysteinemia. The study found that the nutraceutical group had significantly greater HCys reduction compared to the control group.
Paper Details　
Original Abstract of the Article :
Although the role of homocysteine (HCys) in secondary cardiovascular prevention has been scaled down, hyper-homocysteinemia remains a risk factor for cerebrovascular events. The aim of this study was to investigate the efficacy of nutraceuticals in lowering HCys serum levels versus a conventional vi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/27655522

データ提供：米国国立医学図書館（NLM）

Homocysteine Levels and Cardiovascular Health: A Nutritional Approach

[Homocysteine (HCys)] is an amino acid that has been linked to [cardiovascular disease]. While its role in secondary prevention has been reevaluated, [hyper-homocysteinemia] remains a risk factor for cerebrovascular events. This study investigated the efficacy of [nutraceuticals] in lowering HCys levels in hypertensive subjects at low cardiovascular risk compared to conventional vitamin supplementation.

Nutraceuticals for Cardiovascular Health

This study reveals the potential benefits of a [nutraceutical] approach for lowering HCys levels in hypertensive subjects. It's like finding a hidden oasis in the desert - a source of nourishment for better cardiovascular health. The study found that the [nutraceutical group] experienced a significantly greater reduction in HCys levels compared to the [control group]. The findings highlight the potential of nutraceuticals as a safe and effective strategy for managing HCys levels and potentially reducing the risk of cerebrovascular events.

Dr. Camel's Conclusion

This study, like a camel caravan traversing the desert, demonstrates the importance of a comprehensive approach to cardiovascular health. By exploring the benefits of nutraceuticals, we gain valuable insights into the potential for nutritional interventions to address risk factors and promote overall well-being. Remember, just as a camel relies on nourishment for its journey, our bodies also need proper nutrition to thrive.
Date :
  1. Date Completed 2017-02-02
  2. Date Revised 2017-02-02
Further Info :

Pubmed ID

27655522

DOI: Digital Object Identifier

45

Related Literature

Article Analysis
・Side Effects of betaine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.